GlassScriptPrepare for your visit
Astha Gupta
Nephrology (Internal Medicine) · Philadelphia, PA · NPI 1659659407
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,083.42
in general payments reported to CMS, 2019-2025 · $873 in 2025
The $873 reported for 2025 was more than what 75% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Who reported paying
General payments only, top 6 by amount.
- Vifor Pharma, INC. $880.92
- Astrazeneca Pharmaceuticals LP $701.30
- Aurinia Pharma U.S., INC. $376.14
- Bayer Healthcare Pharmaceuticals INC. $353.50
- Amgen INC. $283.41
- Novartis Pharmaceuticals Corporation $249.04
Drugs and devices associated with these payments
Veltassa Ibsrela Tavneos Kerendia Farxiga Vafseo Vanrafia Lupkynis Parsabiv Purified Cortrophin Gel Velphoro Crysvita
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Astha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1377394/astha-gupta